FDA Inspection 1264243 — Minsheng Group Shaoxing Pharmaceutical Co., Ltd.
The FDA completed an inspection of Minsheng Group Shaoxing Pharmaceutical Co., Ltd. on November 15, 2024 in Shaoxing. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions were found but do not meet the threshold for regulatory action). Product area: Drugs.
Inspection Details
- Classification
- Voluntary Action Indicated (VAI) (VAI)
- End Date
- November 15, 2024
- Fiscal Year
- 2025
- Product Type
- Drugs
- Project Area
- Drug Quality Assurance
- Location
- Shaoxing (China)